<VariationArchive VariationID="5381" VariationName="NM_003227.4(TFR2):c.88dup (p.Arg30fs)" VariationType="Duplication" Accession="VCV000005381" Version="10" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="20420" VariationID="5381">
      <GeneList>
        <Gene Symbol="TFR2" FullName="transferrin receptor 2" GeneID="7036" HGNC_ID="HGNC:11762" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7q22.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100620420" stop="100641552" display_start="100620420" display_stop="100641552" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100218038" stop="100239172" display_start="100218038" display_stop="100239172" Strand="-" />
          </Location>
          <OMIM>604720</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_003227.4(TFR2):c.88dup (p.Arg30fs)</Name>
      <CanonicalSPDI>NC_000007.14:100641173:GGGGG:GGGGGG</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>7q22.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="100641173" stop="100641174" display_start="100641173" display_stop="100641174" variantLength="1" positionVCF="100641173" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="100238796" stop="100238797" display_start="100238796" display_stop="100238797" variantLength="1" positionVCF="100238796" referenceAlleleVCF="C" alternateAlleleVCF="CG" />
      </Location>
      <OtherNameList>
        <Name>E60Ter</Name>
        <Name>ins88C</Name>
      </OtherNameList>
      <ProteinChange>R30fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007989.1" sequenceAccession="NG_007989" sequenceVersion="1" change="g.5377dup">
            <Expression>NG_007989.1:g.5377dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003227.4" sequenceAccession="NM_003227" sequenceVersion="4" change="c.88dup" MANESelect="true">
            <Expression>NM_003227.4:c.88dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003218.2" sequenceAccession="NP_003218" sequenceVersion="2" change="p.Arg30fs">
            <Expression>NP_003218.2:p.Arg30fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.100238801dup" Assembly="GRCh37">
            <Expression>NC_000007.13:g.100238801dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.100641178dup" Assembly="GRCh38">
            <Expression>NC_000007.14:g.100641178dup</Expression>
          </NucleotideExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef ID="CA340409" DB="ClinGen" />
        <XRef Type="Allelic variant" ID="604720.0002" DB="OMIM" />
        <XRef Type="rs" ID="80338877" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_003227.4(TFR2):c.88dup (p.Arg30fs) AND Hemochromatosis type 3" Accession="RCV000005712" Version="5">
        <ClassifiedConditionList TraitSetID="1502">
          <ClassifiedCondition DB="MedGen" ID="C1858664">Hemochromatosis type 3</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2001-05-01" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_003227.4(TFR2):c.88dup (p.Arg30fs) AND Hereditary hemochromatosis" Accession="RCV001381389" Version="6">
        <ClassifiedConditionList TraitSetID="21210">
          <ClassifiedCondition DB="MedGen" ID="C0392514">Hereditary hemochromatosis</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2023-10-18" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2023-10-18" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2013-04-04" MostRecentSubmission="2024-02-14">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">11313241</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">23600741</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26029709</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">26408288</ID>
        </Citation>
        <Citation Type="review" Abbrev="GeneReviews">
          <ID Source="PubMed">20301523</ID>
          <ID Source="BookShelf">NBK1349</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="21210" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="33108" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Hereditary hemochromatosis</ElementValue>
                <XRef ID="Hereditary+hemochromatosis/8521" DB="Genetic Alliance" />
                <XRef ID="MONDO:0006507" DB="MONDO" />
                <XRef ID="35400008" DB="SNOMED CT" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">HH</ElementValue>
                <XRef Type="MIM" ID="235200" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="disease mechanism" integerValue="273">loss of function</Attribute>
                <XRef ID="GTR000603934" DB="Genetic Testing Registry (GTR)" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="public definition">HFE hemochromatosis is characterized by inappropriately high absorption of iron by the small intestinal mucosa. The phenotypic spectrum of HFE hemochromatosis includes: Persons with clinical HFE hemochromatosis, in whom manifestations of end-organ damage secondary to iron overload are present; Individuals with biochemical HFE hemochromatosis, in whom transferrin-iron saturation is increased and the only evidence of iron overload is increased serum ferritin concentration; and Non-expressing p.Cys282Tyr homozygotes, in whom neither clinical manifestations of HFE hemochromatosis nor iron overload are present. Clinical HFE hemochromatosis is characterized by excessive storage of iron in the liver, skin, pancreas, heart, joints, and anterior pituitary gland. In untreated individuals, early symptoms include: abdominal pain, weakness, lethargy, weight loss, arthralgias, diabetes mellitus; and increased risk of cirrhosis when the serum ferritin is higher than 1,000 ng/mL. Other findings may include progressive increase in skin pigmentation, congestive heart failure, and/or arrhythmias, arthritis, and hypogonadism. Clinical HFE hemochromatosis is more common in men than women.</Attribute>
                <XRef ID="NBK1440" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10746" />
                <XRef ID="10746" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301613</ID>
                <ID Source="BookShelf">NBK1440</ID>
              </Citation>
              <Citation Type="Translational/Evidence-based" Abbrev="EuroGenetest, 2010">
                <ID Source="pmc">2987432</ID>
              </Citation>
              <Citation Type="general" Abbrev="USPSTF, 2006">
                <ID Source="PubMed">16880462</ID>
              </Citation>
              <Citation Type="general" Abbrev="AASLD, 2011">
                <ID Source="pmc">3149125</ID>
              </Citation>
              <XRef ID="C0392514" DB="MedGen" />
              <XRef ID="MONDO:0006507" DB="MONDO" />
              <XRef Type="Phenotypic series" ID="PS235200" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="1502" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="1638" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Hemochromatosis due to defect in transferrin receptor 2</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">TFR2-Related Hereditary Hemochromatosis</ElementValue>
                <XRef ID="NBK1349" DB="GeneReviews" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary hemochromatosis type 3</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Hemochromatosis type 3</ElementValue>
                <XRef ID="Hemochromatosis+type+3/3290" DB="Genetic Alliance" />
                <XRef ID="MONDO:0011417" DB="MONDO" />
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">HFE3</ElementValue>
                <XRef Type="MIM" ID="604250" DB="OMIM" />
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">TFR2-related hereditary hemochromatosis (TFR2-HHC) is characterized by increased intestinal iron absorption resulting in iron accumulation in the liver, heart, pancreas, and endocrine organs. Age of onset is earlier than in HFE-HHC. The majority of individuals present with signs and symptoms of iron overload in the third decade (e.g., weakness, fatigue, abdominal pain, hepatomegaly, arthritis, arthralgia, progressive increase in skin pigmentation). Others present as young adults with nonspecific symptoms and abnormal serum iron studies or as adults with abnormal serum iron studies and signs of organ involvement including cirrhosis, diabetes mellitus, and arthropathy.</Attribute>
                <XRef ID="NBK1349" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="10093" />
                <XRef ID="10093" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301523</ID>
                <ID Source="BookShelf">NBK1349</ID>
              </Citation>
              <XRef ID="225123" DB="Orphanet" />
              <XRef ID="C1858664" DB="MedGen" />
              <XRef ID="MONDO:0011417" DB="MONDO" />
              <XRef Type="MIM" ID="604250" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="25894" SubmissionDate="2018-10-24" DateLastUpdated="2018-10-28" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="604720.0002_HEMOCHROMATOSIS, TYPE 3" title="TFR2, 1-BP INS, 84C_HEMOCHROMATOSIS, TYPE 3" />
        <ClinVarAccession Accession="SCV000025894" DateUpdated="2018-10-28" DateCreated="2013-04-04" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2001-05-01">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In all affected members of a large inbred family in Campania in southern Italy segregating hemochromatosis (HFE3; 604250), Roetto et al. (2001) found a 1-bp insertion of a cytosine residue in homozygous state in exon 2 in a polyC tract (84-88 insC). The mutation resulted in a frameshift followed by a premature stop codon, a glu60-to-ter (E60X) substitution. Because of consanguinity, a pseudodominant pedigree pattern was observed in an affected father and his 3 affected children in one branch of the family. Heterozygosity was not associated with iron overload, even in individuals also heterozygous for H63D (613609.0002) at the HFE locus or for the beta-thalassemia trait.</Attribute>
              <Citation>
                <ID Source="PubMed">11313241</ID>
              </Citation>
              <XRef DB="OMIM" ID="604250" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TFR2" />
          </GeneList>
          <Name>TFR2, 1-BP INS, 84C</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">1-BP INS, 84C</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="604720.0002" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">HEMOCHROMATOSIS, TYPE 3</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="41021" SubmissionDate="2022-08-15" DateLastUpdated="2022-10-01" DateCreated="2013-04-04">
        <ClinVarSubmissionID localKey="NM_003227.3:c.88_89insC|OMIM:604250" submittedAssembly="not applicable" />
        <ClinVarAccession Accession="SCV000041021" DateUpdated="2022-10-01" DateCreated="2013-04-04" Type="SCV" Version="3" SubmitterName="GeneReviews" OrgID="500062" OrganizationCategory="resource" OrgAbbreviation="GeneReviews" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>no classification provided</ReviewStatus>
          <GermlineClassification>not provided</GermlineClassification>
          <Citation>
            <ID Source="BookShelf">NBK1349</ID>
          </Citation>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>ins88C</Name>
            <Name>E60Ter</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003227.3:c.88_89insC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1858664" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11808016</SubmissionName>
          <SubmissionName>SUB11927816</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3105373" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-14" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="4870760|MedGen:C0392514" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579766" DateUpdated="2024-02-14" DateCreated="2021-05-10" Type="SCV" Version="4" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2023-10-18">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">23600741</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26029709</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">11313241</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">26408288</ID>
          </Citation>
          <Comment>This sequence change creates a premature translational stop signal (p.Arg30Profs*31) in the TFR2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in TFR2 are known to be pathogenic (PMID: 23600741, 26029709). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with hemochromatosis (PMID: 11313241, 26408288). It has also been observed to segregate with disease in related individuals. This variant is also known as 84-88 insC (E60X). ClinVar contains an entry for this variant (Variation ID: 5381). For these reasons, this variant has been classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="TFR2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000007.13:g.100238796_100238797insG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C0392514" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB11431369</SubmissionName>
          <SubmissionName>SUB12508014</SubmissionName>
          <SubmissionName>SUB14200283</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="3105373" TraitType="Disease" MappingType="XRef" MappingValue="C0392514" MappingRef="MedGen">
        <MedGen CUI="C0392514" Name="Hereditary hemochromatosis" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="25894" TraitType="Disease" MappingType="Name" MappingValue="HEMOCHROMATOSIS, TYPE 3" MappingRef="Preferred">
        <MedGen CUI="C1858664" Name="Hemochromatosis type 3" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="41021" TraitType="Disease" MappingType="XRef" MappingValue="C1858664" MappingRef="MedGen">
        <MedGen CUI="C1858664" Name="Hemochromatosis type 3" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

